[Risk and benefit of the treatment of bulky retroperitoneal teratoid tumors].
Inductive polychemotherapy of germinal cell tumors in advanced stages (T0-4N3,4M0,1) is effective, but is accompanied by serious side effects. If partial remission occurs, it is necessary to resect the residual tumor. The complications involved in this salvage operation are tolerable in relation to the prognosis. In a retrospective analysis, we evaluated the occurrence of toxic side effects and the frequency of intra- and postoperative complications in 128 patients with retroperitoneal teratoid bulky tumor. After a follow-up period of 3-110 months (mean = 43 months), 91 patients (71%) are still alive with no evidence of disease; 28 patients (22%) have died of apparent tumor progression.
Jaeger
N
N
Urologische Universittsklinik, Bonn.
Weissbach
L
L
Hartlapp
J H
JH
Vahlensieck
W
W
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D009367:Neoplasm Staging; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D011183:Postoperative Complications; D011379:Prognosis; D012186:Retroperitoneal Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*
Risiko und Nutzen der Behandlung retroperitonealer teratoider "Bulky"- Tumoren.